{
    "info": {
        "nct_id": "NCT04009668",
        "official_title": "Precision Medicine Proof of Concept for Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease",
        "inclusion_criteria": "* Kidney biopsy confirmed Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)\n* For Minimal Change Disease patients only, history of resistance to corticosteroid therapy\n* Increased urinary excretion of biomarkers of Tumor Necrosis Factor (TNF) activation (MCP1/Cr and/ or TIMP1/Cr) at study screening\n* eGFR>30 ml/min/1.73 m2 at screening\n* Urine protein:creatinine ratio ≥1.5 g/g at screening\n* Weight >15 kg\n* Stable therapy with angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and oral immunosuppression agents for at least 30 days prior to enrollment\n* Birth control use in females of child bearing potential\n* Informed consent and assent if applicable\nHealthy volunteers allowed\nMust have minimum age of 6 Years\nMust have maximum age of 80 Years",
        "exclusion_criteria": "* Kidney or other solid organ or bone marrow transplant recipient\n* Allergy or intolerance to investigational agent\n* Secondary Focal Segmental Glomerulosclerosis (FSGS)\n* Severe obesity\n* Live virus vaccine in the past 3 months\n* Malignancy, current or in the past 5 years\n* Active local or systemic bacterial, fungal or viral infection\n* Active or latent Hepatitis B, Hepatitis C, HIV, or tuberculosis\n* History of demyelinating disease, e.g. Multiple Sclerosis or Guillain-Barre\n* History of heart failure\n* Active liver disease\n* Systemic lupus erythematosus or ANA > 1:80\n* History of inflammatory bowel disease, e.g. ulcerative colitis or Crohns disease\n* Cyclophosphamide in past 90 days, Rituximab in the past 180 days\n* Pregnancy or nursing\n* Blood white blood cell count <4,500/mm3; Hg <9 g/dL; Platelet count <150,000/mm3 at enrollment. - Use of an erythropoiesis stimulating agent will not be an exclusion criterion.\n* Concurrent use of interleukin-1 antagonist (Anakinra), other TNF blocking agent, methotrexate or abatacept\n* Diabetes Mellitus",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have minimum age of 6 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 6 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Kidney biopsy confirmed Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)",
            "criterions": [
                {
                    "exact_snippets": "Kidney biopsy confirmed Focal Segmental Glomerulosclerosis (FSGS)",
                    "criterion": "Focal Segmental Glomerulosclerosis (FSGS)",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis confirmation method",
                            "expected_value": "kidney biopsy"
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Kidney biopsy confirmed ... Minimal Change Disease (MCD)",
                    "criterion": "Minimal Change Disease (MCD)",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis confirmation method",
                            "expected_value": "kidney biopsy"
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* For Minimal Change Disease patients only, history of resistance to corticosteroid therapy",
            "criterions": [
                {
                    "exact_snippets": "Minimal Change Disease patients only",
                    "criterion": "diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": "Minimal Change Disease"
                        }
                    ]
                },
                {
                    "exact_snippets": "history of resistance to corticosteroid therapy",
                    "criterion": "corticosteroid therapy resistance",
                    "requirements": [
                        {
                            "requirement_type": "history of resistance",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Increased urinary excretion of biomarkers of Tumor Necrosis Factor (TNF) activation (MCP1/Cr and/ or TIMP1/Cr) at study screening",
            "criterions": [
                {
                    "exact_snippets": "Increased urinary excretion of biomarkers of Tumor Necrosis Factor (TNF) activation (MCP1/Cr and/ or TIMP1/Cr) at study screening",
                    "criterion": "urinary excretion of MCP1/Cr",
                    "requirements": [
                        {
                            "requirement_type": "level",
                            "expected_value": {
                                "operator": ">",
                                "value": 0,
                                "unit": "baseline/normal"
                            }
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "at study screening"
                        }
                    ]
                },
                {
                    "exact_snippets": "Increased urinary excretion of biomarkers of Tumor Necrosis Factor (TNF) activation (MCP1/Cr and/ or TIMP1/Cr) at study screening",
                    "criterion": "urinary excretion of TIMP1/Cr",
                    "requirements": [
                        {
                            "requirement_type": "level",
                            "expected_value": {
                                "operator": ">",
                                "value": 0,
                                "unit": "baseline/normal"
                            }
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "at study screening"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* eGFR>30 ml/min/1.73 m2 at screening",
            "criterions": [
                {
                    "exact_snippets": "eGFR>30 ml/min/1.73 m2 at screening",
                    "criterion": "eGFR",
                    "requirements": [
                        {
                            "requirement_type": "value at screening",
                            "expected_value": {
                                "operator": ">",
                                "value": 30,
                                "unit": "ml/min/1.73 m2"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Urine protein:creatinine ratio ≥1.5 g/g at screening",
            "criterions": [
                {
                    "exact_snippets": "Urine protein:creatinine ratio ≥1.5 g/g at screening",
                    "criterion": "urine protein:creatinine ratio",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1.5,
                                "unit": "g/g"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Weight >15 kg",
            "criterions": [
                {
                    "exact_snippets": "Weight >15 kg",
                    "criterion": "weight",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 15,
                                "unit": "kg"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Birth control use in females of child bearing potential",
            "criterions": [
                {
                    "exact_snippets": "Birth control use in females of child bearing potential",
                    "criterion": "birth control use",
                    "requirements": [
                        {
                            "requirement_type": "applicability",
                            "expected_value": "females of child bearing potential"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Stable therapy with angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and oral immunosuppression agents for at least 30 days prior to enrollment",
            "criterions": [
                {
                    "exact_snippets": "Stable therapy with angiotensin converting enzyme inhibitors ... for at least 30 days prior to enrollment",
                    "criterion": "angiotensin converting enzyme inhibitor therapy",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 30,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Stable therapy with ... angiotensin receptor blockers ... for at least 30 days prior to enrollment",
                    "criterion": "angiotensin receptor blocker therapy",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 30,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Stable therapy with ... oral immunosuppression agents for at least 30 days prior to enrollment",
                    "criterion": "oral immunosuppression agent therapy",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 30,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Informed consent and assent if applicable",
            "criterions": [
                {
                    "exact_snippets": "Informed consent",
                    "criterion": "informed consent",
                    "requirements": [
                        {
                            "requirement_type": "obtained",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "assent if applicable",
                    "criterion": "assent",
                    "requirements": [
                        {
                            "requirement_type": "obtained_if_applicable",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 80 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 80 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 80,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* History of heart failure",
            "criterions": [
                {
                    "exact_snippets": "History of heart failure",
                    "criterion": "heart failure",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Secondary Focal Segmental Glomerulosclerosis (FSGS)",
            "criterions": [
                {
                    "exact_snippets": "Secondary Focal Segmental Glomerulosclerosis (FSGS)",
                    "criterion": "secondary focal segmental glomerulosclerosis (FSGS)",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Severe obesity",
            "criterions": [
                {
                    "exact_snippets": "Severe obesity",
                    "criterion": "obesity",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Allergy or intolerance to investigational agent",
            "criterions": [
                {
                    "exact_snippets": "Allergy or intolerance to investigational agent",
                    "criterion": "allergy to investigational agent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Allergy or intolerance to investigational agent",
                    "criterion": "intolerance to investigational agent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active or latent Hepatitis B, Hepatitis C, HIV, or tuberculosis",
            "criterions": [
                {
                    "exact_snippets": "Active or latent Hepatitis B",
                    "criterion": "Hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Hepatitis C",
                    "criterion": "Hepatitis C infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "HIV",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "tuberculosis",
                    "criterion": "tuberculosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Malignancy, current or in the past 5 years",
            "criterions": [
                {
                    "exact_snippets": "Malignancy, current or in the past 5 years",
                    "criterion": "malignancy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "=",
                                        "value": 1,
                                        "unit": "presence"
                                    }
                                ]
                            }
                        },
                        {
                            "requirement_type": "timeframe",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 5,
                                        "unit": "years"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diabetes Mellitus",
            "criterions": [
                {
                    "exact_snippets": "Diabetes Mellitus",
                    "criterion": "diabetes mellitus",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Blood white blood cell count <4,500/mm3; Hg <9 g/dL; Platelet count <150,000/mm3 at enrollment. - Use of an erythropoiesis stimulating agent will not be an exclusion criterion.",
            "criterions": [
                {
                    "exact_snippets": "Blood white blood cell count <4,500/mm3",
                    "criterion": "white blood cell count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 4500,
                                "unit": "mm3"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Hg <9 g/dL",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 9,
                                "unit": "g/dL"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Platelet count <150,000/mm3 at enrollment",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 150000,
                                "unit": "mm3"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pregnancy or nursing",
            "criterions": [
                {
                    "exact_snippets": "Pregnancy",
                    "criterion": "pregnancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "nursing",
                    "criterion": "nursing",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of inflammatory bowel disease, e.g. ulcerative colitis or Crohns disease",
            "criterions": [
                {
                    "exact_snippets": "History of inflammatory bowel disease",
                    "criterion": "inflammatory bowel disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "ulcerative colitis",
                    "criterion": "ulcerative colitis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Crohns disease",
                    "criterion": "Crohn's disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active liver disease",
            "criterions": [
                {
                    "exact_snippets": "Active liver disease",
                    "criterion": "liver disease",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active local or systemic bacterial, fungal or viral infection",
            "criterions": [
                {
                    "exact_snippets": "Active local or systemic bacterial, fungal or viral infection",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "location",
                            "expected_value": [
                                "local",
                                "systemic"
                            ]
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "bacterial",
                                "fungal",
                                "viral"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of demyelinating disease, e.g. Multiple Sclerosis or Guillain-Barre",
            "criterions": [
                {
                    "exact_snippets": "History of demyelinating disease, e.g. Multiple Sclerosis or Guillain-Barre",
                    "criterion": "demyelinating disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Multiple Sclerosis",
                    "criterion": "Multiple Sclerosis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Guillain-Barre",
                    "criterion": "Guillain-Barre syndrome",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Kidney or other solid organ or bone marrow transplant recipient",
            "criterions": [
                {
                    "exact_snippets": "Kidney or other solid organ or bone marrow transplant recipient",
                    "criterion": "transplant recipient status",
                    "requirements": [
                        {
                            "requirement_type": "history of transplantation",
                            "expected_value": [
                                "kidney",
                                "other solid organ",
                                "bone marrow"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Concurrent use of interleukin-1 antagonist (Anakinra), other TNF blocking agent, methotrexate or abatacept",
            "criterions": [
                {
                    "exact_snippets": "Concurrent use of interleukin-1 antagonist (Anakinra)",
                    "criterion": "interleukin-1 antagonist (Anakinra) use",
                    "requirements": [
                        {
                            "requirement_type": "concurrent use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Concurrent use of ... other TNF blocking agent",
                    "criterion": "TNF blocking agent use",
                    "requirements": [
                        {
                            "requirement_type": "concurrent use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Concurrent use of ... methotrexate",
                    "criterion": "methotrexate use",
                    "requirements": [
                        {
                            "requirement_type": "concurrent use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Concurrent use of ... abatacept",
                    "criterion": "abatacept use",
                    "requirements": [
                        {
                            "requirement_type": "concurrent use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Cyclophosphamide in past 90 days, Rituximab in the past 180 days",
            "criterions": [
                {
                    "exact_snippets": "Cyclophosphamide in past 90 days",
                    "criterion": "Cyclophosphamide administration",
                    "requirements": [
                        {
                            "requirement_type": "time since last administration",
                            "expected_value": {
                                "operator": ">",
                                "value": 90,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Rituximab in the past 180 days",
                    "criterion": "Rituximab administration",
                    "requirements": [
                        {
                            "requirement_type": "time since last administration",
                            "expected_value": {
                                "operator": ">",
                                "value": 180,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Systemic lupus erythematosus or ANA > 1:80",
            "criterions": [
                {
                    "exact_snippets": "Systemic lupus erythematosus",
                    "criterion": "systemic lupus erythematosus",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "ANA > 1:80",
                    "criterion": "antinuclear antibody (ANA) titer",
                    "requirements": [
                        {
                            "requirement_type": "titer",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "80"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Live virus vaccine in the past 3 months",
            "criterions": [
                {
                    "exact_snippets": "Live virus vaccine in the past 3 months",
                    "criterion": "live virus vaccine administration",
                    "requirements": [
                        {
                            "requirement_type": "time since administration",
                            "expected_value": {
                                "operator": "<",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}